Oct. 20 Meeting Tentatively Scheduled For User Fees, Performance Goals
This article was originally published in The Gray Sheet
Executive Summary
FDA expects to meet with device industry reps Oct. 20 to review ongoing concerns with the user fee program, including whether the baseline data used to set MDUFMA performance goals were appropriate